News

TORONTO, Nov 5 (LifeSiteNews.com) – Roberts Pharmaceuticals, The Canadian distributor of the abortifacient “emergency contraceptive” kit Preven, began its promised “aggressive” marketing scheme today with radio advertisements and a front page article courtesy of the Globe and Mail. Dr Albert Yuzpe, a spokesperson for Roberts said “This isn’t an abortion pill. It will not disrupt a pregnancy that is established.” To its credit, the paper explained that while “proponents of the morning-after pill say it is not an abortion drug because pregnancy does not begin until after a fertilized egg is securely implanted in the womb… its opponents are equally adamant that life begins the moment a sperm fertilizes an egg.” 

LifeSite has found a revealing quote from the president of Roberts’ US provider Gynetics in relation to the drug’s abortifacient effect. The November 1998 issue of the Canadian Pharmaceutical Journal notes that “while additional doses of oral contraceptives have been used for two decades to Preven ovum implantation for up to 72 hours after intercourse, company president Roderick Mackenzie says his product, Preven will be the first in Canada sold solely for that purpose.” 

For a comprehensive report on Preven see LifeSite at:

Early Abortion Drug Available Over the Counter

Comments

Commenting Guidelines

LifeSiteNews welcomes thoughtful, respectful comments that add useful information or insights. Demeaning, hostile or propagandistic comments, and streams not related to the storyline, will be removed.

LSN commenting is not for frequent personal blogging, on-going debates or theological or other disputes between commenters.

Multiple comments from one person under a story are discouraged (suggested maximum of three). Capitalized sentences or comments will be removed (Internet shouting).

LifeSiteNews gives priority to pro-life, pro-family commenters and reserves the right to edit or remove comments.

Comments under LifeSiteNews stories do not necessarily represent the views of LifeSiteNews.